Introduction
The Notch gene was discovered almost 90 years ago by Morgan and colleagues who observed that partial loss of function results in notches at the wing margin in flies (Drosophila melanogaster) [1] . Decades later in loss of function experiments, Notch was found to cause a "neurogenic" phenotype, where cells destined to become epidermis switch fate and give rise to neural tissue, reviewed in [2, 3] . In the early eighties, the Notch gene was found to encode a 300kDa single-pass transmembrane receptor. The extracellular domain of the Notch receptor contains 36 epidermal growth factor (EGF)-like repeats essential for ligand binding. The intracellular domain is involved in cellular signaling and contains multiple conserved protein domains. Subsequently, Notch-like molecules have been identified from C. elegans (LIN-12) to humans, playing important, and apparently conserved, functional roles in development. In mammals, four Notch receptors (Notch 1 -4) and five transmembrane ligands (Jagged1, Jagged2, Delta-like1, Delta-like3, and Deltalike4) are described so far. Although Notch was originally classified as a neurogenic gene even the first characterization of Drosophila embryos made it clear that Notch signals are highly pleiotropic, thereby affecting many tissues.
The Notch signaling cascade appears remarkably simple with apparently no second messengers involved. However, the role of Notch signaling and the activation of downstream genes in a given tissue remain often complex and unpredictable. Here, we review in depth what is known so far about transcriptional regulation mediated by Notch. Subsequently, we summarize the current knowledge about Notch target genes and, in a broader context, the relevance of Notch signaling in cell differentiation and cancer.
Molecular mechanism of transcriptional regulation at Notch target genes
The Notch signaling cascade Notch signaling is activated upon cell-to-cell contact as a result of interactions between Notch receptors and their ligands (Delta or Jagged). At the molecular level, triggering of Notch receptor by ligand binding promotes two proteolytic cleavage events at the Notch receptor (Fig. 1) . The first cleavage is catalyzed by the ADAM-family of metalloproteases, whereas the second cleavage is mediated by g-secretase, an enzyme complex that contains presenilin, nicastrin, PEN2 and APH1, reviewed in [4] . The second cleavage releases the Notch intracellular domain (NICD), which then translocates to the nucleus and acts as a transcriptional coactivator. NICD cannot bind directly to DNA but heterodimerizes with the DNA binding protein RBP-J (recombination signal sequence-binding protein Jk, also called CSL, CBF1, Su(H) and LAG-1) and activates transcription of genes containing RBP-J binding sites. Interestingly, RBP-J was originally identified as a repressor of transcription by Vales and colleagues [5] . When studying the promoter region of the adenovirus pIX gene, a 10bp repressive element was characterized and it was shown that RBP-J is the factor that binds to this element. Subsequently, the RBP-J binding site was placed in reporter assays next to other transcriptional activators Gal4-VP16 or SP1, and it was shown that RBP-J could interfere with transcriptional activation. Other investigators also demonstrated the RBP-J repressive activity by placing multiple RBP-J binding sites at a TK-promoter element [6] . The RBP-J mediated repression could either be relieved by addition of the viral activator EBNA2 (see also below section on Notch in cancer, EpsteinBarr virus) or by the fusion of RBP-J to VP16 activation domain. The RBP-J activator/repressor paradox was resolved with the realization that repression and activation via RBP-J involves the recruitment of distinct protein complexes, which influence transcription of target genes in a positive or negative fashion. In the absence of ligand, hence without nuclear NICD, RBP-J represses Notch target genes through the recruitment of corepressor complexes. NICD binding to RBP-J is crucial for the switch from repressed to activated state. NICD first displaces corepressors from RBP-J, resulting in derepression of promoters containing RBP-J binding sites and subsequently recruits a coactivator complex to activate transcription of Notch target genes.
Notch target genes
Although signals mediated through Notch receptors have diverse outcomes, only a fairly limited set of Notch target genes have been identified in various cellular and developmental contexts. The hairy/enhancer of split (Hes) genes are highly conserved proteins that are regulated by Notch in multiple cell types, reviewed in [7, 8] . Hairy/Enhancer of split family genes were first described as neurogenic genes in Drosophila (like Notch, Deltex and Mastermind), since embryos lacking the function of these genes showed an increased number of neuroblasts at the expense of epidermal precursors, reviewed in [2, 9] . Several lines of evidence have suggested that these genes are indeed direct Notch target genes: a) The promoters of Hes1, Hes5 and Hes7 as well as Hey1, Hey2 and HeyL (subfamily of Hes, related with YRPW motif) can be activated by a constitutive active form of Notch1 [10 -12] , reviewed in [7] ; constitutive active Notch describes a mutant of Notch that is continuously proteolytically processed and migrating to the nucleus, b) endogenous Hey1 and Hey2 show an upregulation by NICD in several different cell lines [13] , c) in co-culture experiments with Notch-ligand expressing cells, that achieve a more physiological level of Notch signaling, these genes are upregulated as well [13 -15] ; these experiments were also performed in the presence of cyclohexamide, an inhibitor of protein synthesis, to exclude secondary effects, d) k-secretase inhibitor DAPT, which prevents cleavage of Notch, was added to Tcell leukemia cell lines which show constitutive-active Notch signaling; subsequent microarray analysis identified again members of this transcription factor family as direct Notch target genes [16] . Therefore, in mammals, the best-described Notch target genes are indeed the transcription factors Hes1, Hes5 and Hey1 [8, 17] . Hes and Hey proteins are helix-loop-helix transcription factors that function as transcriptional repressors. Overexpression of Hes1 and Hes5 in bone marrow partly inhibits B-cell development [18] . Hes1 deficient mice are not viable and display multiple developmental defects, reviewed in [7] . CD25 (IL2-R and preTa, pre-T-cell receptor alphachain) were also shown to be Notch target genes in T-cells [19, 20] . In later stages of T-cell development, the transcription factor GATA3, a master regulator for Tcell development and later for Th1/2 lineage decision, is a direct Notch target gene [21, 22] . Flavell and colleagues could show that Th2-mediated immunity depends on either RBP-J or Notch [22] and that the GATA3 promoter contains bona fide RBP-J binding sites. In addition, the Pear lab demonstrated, that the expression of dominant-negative mastermindlike-1 (dnMAML) results in impaired GATA3 transcription levels and subsequently impaired IL4 production [21] . Two other Notch target genes, NRARP and Deltex-1 were shown to be potent negative regulators of Notch signaling [23, 24] . Furthermore, Notch target genes implicated in cancer are c-myc [16, 25, 26] , cyclinD1 [27] and p21/Waf1 [28] . Other Notch target genes are NFkB2 [29] , Ifi-202, Ifi-204, Ifi-D3, and ADAM19 [19] . A number of other genes have been reported including Notch1 itself and Notch3 [16] , bcl-2 [30] and E2A [31] and HoxA5, 9 and 10 [32] .
What happens at Notch target genes in the absence of activated Notch? In the absence of Notch, RBP-J is retained at the gene regulatory elements of Notch target genes ( Fig. 1) and acts there as a transcriptional repressor. Transcriptional repression seems to be mediated by different mechanisms. Based on biochemical experiments, it was proposed that RBP-J can interact directly with TFIID, a general transcription factor [33] or that RBP-J can recruit histone deacetylase-containing complexes. Previously, at least three different interactions between RBP-J and corepressor complexes have been described: a complex containing SMRT/mSin3A/ HDAC-1 (SMRT, Silencing Mediator for Retinoic acid and Thyroid hormone receptor; HDAC-1, histone deacetylase-1) or NCor/mSin3A/HDAC-1 complex [34] and a CIR/SAP30/HDAC-2 complex [35] . So far, the functional relevance of these biochemical findings still remains to be seen. We recently characterized an RBP-associated repressor complex composed of corepressors RBP-J, SHARP (SMRT and HDAC associated repressor protein), CtBP (C-terminal binding protein) and CtIP (CtBP interacting protein) [36] . The relevance of this finding is supported by genetic data in Drosophila where RBP-J homologue Su(H) can recruit the corepressor dCtBP [37, 38] . Analogous to Drosophila dCtBP mutants, CtBP knock-out mice reveal that this protein plays a pivotal role in embryogenesis [39] . By now, several other groups have shown that CtBP is found in complex with histone demethylase LSD1/CoREST [40] (see also below).
Epigenetic regulation of Notch target genes
Although precise mechanisms of epigenetic regulation at Notch target genes are not completely understood, cumulating evidence suggests that histone modifications play a pivotal role in this process. The presence of specific post-translational histone modifications define transcriptionally inactive or active chromatin domains [41 -44] . Acetylation and methylation represent the most common modifications of the histone tails. This epigenetic, or non-DNA encoded information, at promoters determines the outcome of a transcriptional response in a specific cell type. The precise mechanisms of epigenetic regulation of Notch target genes are not yet known, although some histone-modifying enzymes have been implicated in the regulation of Notch target genes. The histone acetyltransferase (HAT) p300 has been shown in complex with RBP-J/Notch and is a positive cofactor for Notch dependent transcription [45, 46] . Functional interactions between Notch and PCAF and GCN5 have also been observed [47] . Furthermore, histone deacetylases have been implicated in repression mediated by the RBP-J/SHARP corepressor complex [34, 48] . There is only very preliminary data available for changes in histone methylation at Notch target genes. So far, Bray and colleagues could demonstrate that dynamic changes in histone methylation of H3K4 occur upon activation of Notch target genes [49] . Interestingly, in Drosophila Bre1, the histone H2B ubiquitin ligase, regulates not only activation of some Notch target genes but also H3K4 methylation [50] . On the other hand, the mammalian histone H3K4 demethylase LSD-1 has been implicated in Notch target gene regulation [51] . The involvement of LSD-1 in the regulation of Notch signaling is further supported by genetic data in C. elegans [52] . Baumeister and colleagues used a suppressor screen of presenilin (C. elegans sel-12), displaying an egg-laying defect and identified members of the HDAC/CoREST/LSD1 complex as genetic interactors. Interestingly, LSD-1 is also part of a corepressor complex containing CtBP [40] which is one component identified in the RBP-J corepressor complex [36 -38, 53] . Specific polycomb complexes, that are known to methylate H3K27, have been proposed to play a negative role in the regulation of Notch target genes [54, 55] . In addition, polycomb component YY1, which is itself a DNA binding protein, has been found to be associated with NICD, to regulate c-myc promoter activity [56] . Interestingly, overexpression of the two polycomb epigenetic silencers, Pipsqueak and Lola, enhance Notch-induced overproliferation and causes hypermethylation at the Rb tumor suppressor gene [57] .
Finally Bray and colleagues also reported that the histone H3/H4 chaperone Asf1 contributes to repression of Notch target genes, as depletion of Asf1 by RNAi caused derepression of some Notch target genes and Asf and Notch interact genetically [58] .
The RBP-J corepressor and coactivator complexes RBP-J corepressor complex RBP-J is the only transcription factor in the Notch signaling cascade and is therefore a central player. In the absence of Notch, RBP-J recruits a corepressor complex that contains different components at different Notch target genes. In the presence of NICD, the corepressor complex is displaced and a coactivator complex containing Notch and Mastermind is recruited ( Fig. 1 ).
RBP-J itself. RBP-Jk [59] also called CBF1 or KBF2 [60] belongs to the CSL-protein family. CSL stands for CBF1 (human), [61] , Suppressor of Hairless (Drosophila), [62] , Lag-1 (C. elegans), [63] . RBP-J (mouse) [64] , was first isolated from B-cells as a 60kDa DNAbinding protein [59] . It is a highly conserved nuclear protein with 75 % sequence amino acid sequence identity between human and Drosophila [62] that is ubiquitously expressed. The DNA binding sequence was identified as 5-CGTGGGAA-3 [64] . A paralogue of RBP-J, RBP-L, was also described that is almost exclusively expressed in the lung [65] . RBP-L binds to DNA identical to RBP-J. Although RBP-L did not interact with any Notch protein, it was shown to cooperate with EBNA2 in transcriptional activation. RBP-L has been also found in complex with PTF1, which has been proposed to play a role in pancreas development [66] . The physiological role and possible redundancy of the two RBP factors is still unknown. The essential function of RBP-J has been demonstrated by knock-out models in mice where the loss of RBP-J expression exhibited an lethal phenotype in embryonic development at day 10.5 of gestation. Conditional deletion in the hematopoietic system leads to a block in T-cell development and ectopic development of B-cells in the thymus [68] . This phenotype is very similar to Notch1 conditional knock-out mice, indicating that "canonical" Notch signaling (signaling through RBP-J) is the main pathway in lymphoid development.
SKIP (Ski-interacting protein), originally identified by the Hayward lab in a yeast-2-hybrid screen with RBP-J, is evolutionary highly conserved [69] . When part of the corepressor complex, SKIP can interact with corepressor SMRT, thereby recruiting histone deacetylases [34] . Hayward and colleagues have presented data that demonstrates SKIP bridges interactions between RBP-J and corepressors or RBP-J and Notch [69, 70] . This implies that SKIP is part of both RBP transcriptional repression and activation complexes. However chromatin immunoprecipitation experiments from the Jones group suggest that SKIP is only recruited to the promoter when Notch is present [71] .
CIR (CBF1 interacting corepressor) is, like SKIP, also a direct RBP-J binding protein that binds also to HDACs and SAP30 [35] . The function and in vivo relevance of SKIP and CIR still remains to be addressed. The role of histone deacetylases in the RBP-J corepressor complex has been reported by several groups [34, 35, 48, 72] . HDAC1/2 are also part of the LSD1/CoREST/CtBP complex [40] .
KyoT2 is a LIM domain protein and interacts with RBP-J through the binding motif on its C-terminus generated by alternative splicing [73] . It has been shown that KyoT2 can block Notch-or EBNA2 mediated transactivation. KyoT2 has also been shown to recruit Polycomb group proteins HPC2 and Ring1 [54, 74] .
SHARP (SMRT and HDAC associated repressor protein) was originally found in a yeast-2-hybrid screen with SMRT (Silencing Mediator for Retinoid and Thyroid hormone receptor) as a cofactor for nuclear hormone receptors [75] . In our own experiments, the corepressor protein SHARP was found to interact directly with transcription factor RBP-J [48] . SHARP is a 400kDa nuclear protein that is ubiquitously expressed. It is a member of the heterogeneous SPEN-homology (Split-ends) domain family implicated in biological processes from embryogenesis to ageing. SHARP contains RRMs (RNA Recognition Motifs) in the amino-terminal region and a highly conserved SPOC-domain at the very C-terminus [76] and reviewed in [77] ; this domain has been crystallized and contains a highly conserved positively charged patch which is crucial for the interaction with corepressors SMRT/NCoR [78, 79] . The very last 34 amino acids of the SPOC-domain of SHARP are required for binding to corepressors CtIP/CtBP [36] and ETO (Eight-twenty-one) (Fig. 1) [78, 79] . In addition, the SPOC-domain of SHARP can be phosphorylated by Pak1 (p21-activated kinase-1), and hence enhances SHARP corepressor function. It also has been reported by the group of Han that the SHARP C-terminal SPOC-domain can homodimerize [80] . 1634 T. Borggrefe and F. Oswald Notch signaling and gene expression
The mouse homolog of SHARP, MINT (Msx-2-Interacting Nuclear Target), was found in a screen for interacting proteins of transcriptional repressor Msx-2 (Muscle segment homeobox-2), [81] . MINTdeficient mice are embryonic lethal, due to defective heart, pancreas and hematopoietic development [82] . [85] . Interestingly, there is a SHARP-like protein in mouse and men, Rbm15/OTT1, that is implicated in acute megakaryoblastic leukemia [86, 87] and has been shown to interact with RBP-J, although the RBP-J binding site of SHARP is not conserved in Rbm15/ OTT1 [88] . Rbm15/OTT1 deficient mice are characterized by a loss of peripheral B-cells and an increase in stem-myeloid-and megakaryocyte progenitors [89] . Furthermore, the proteins SHARP, OTT1 and SKIP were identified as spliceosomal components [90] and therefore may also be implicated in post-transcriptional processes [91] .
SHARP as a "corepressor hub": CtIP/CtBP, ETO and SMRT Several lines of evidence suggest that SHARP can be involved in recruitment of different corepressor complexes which demonstrates the versatility of Notch regulated gene expression. It is intriguing that, CtIP, ETO and SMRT bind to the same small region of the large 400kDa protein SHARP. In the absence of NICD, the RBP-J/SHARP heterodimer recruits corepressors CtIP/CtBP to Notch target genes [36] , (Fig. 1A) . As mentioned above, this is particularly interesting because of the biochemical and genetic interaction to histone demethylase LSD-1, which was identified as a component of the CtBP corepressor complex [40] . Furthermore, Drosophila Hairless, the functional homolog of SHARP, recruits corepressor dCtBP as well.
Moreover, we most recently demonstrated that ETO is an additional component of the SHARP corepressor complex [78] , (Fig. 1B) . Interestingly, leukemogenic fusion protein AML1/ETO can disturb the normal, repressive function of ETO at Notch target genes. This activating (or derepressing) effect of AML1/ETO may contribute to its oncogenic potential in myeloid leukemia. Our data is supported by the group of Pelicci who performed overexpression of leukemogenic fusion protein AML1/ETO and observed deregulation of some Notch target genes [92] . It still remains to be characterized in detail, which corepressor is utilized at certain target genes in specific cell types. Only in a few cases, like that of SHARP, this was answered in part.
Coactivators of Notch
After engagement of the Notch receptor, proteolytic cleavage events release the intracellular domain of Notch (NICD), which then translocates into the nucleus to displace RBP-J associated corepressors and then recruits coactivators.
NICD itself. The best-described intracellular domain of Notch1 contains five different segments: i) seven tandem-ankyrin repeats, ii) the transactivation domain, iii) a glutamine-rich OPA domain, iv) a proline-, glutamine-, serine-and threonine-rich PEST domain and v) a RAM23 domain [93 -95] . The RAM23 domain contains the nuclear localization signals (NLSs) and is in combination with the ankyrin-repeats responsible for the binding to RBP-J [94, 96] . The region between the ankyrin-repeats and the PEST region is the transactivation domain (TAD) of NICD, [97] . Recently, three other functional regions of NICD have been identified, termed PPD (potential phosphorylated domain), DTS (downregulation targeting sequence) and S4 (for WSSSSP). PPD is located between the ankyrin repeats and PEST domain and was shown to enhance the binding of NICD to RBP-J [98] . DTS is required for endocytic trafficking of Notch and crosstalk with the Ras signaling pathway [99] . S4 is the C-terminal phosphorylation site, important for Notch turnover (see below: CycC/ Cdk8 and phosphorylation of Notch receptor and Mastermind/p300. Mastermind is a member of the Mastermind-like (MAML) family of coactivators [101, 102] , originally identified in genetic screens in Drosophila [2] . Recently, the first detailed view of the coactivator complex was provided by the determination of the structure of full-length RBP-J bound to DNA in combination with a truncated form of NICD and the interacting part of MAML [103] and reviewed in [104, 105] . In Drosophila, the mastermind gene codes for a glutamine-rich protein, indicative for an transcriptional activators. Mammalian MAML was shown to stabilize the RBP/NICD bound to DNA during activation of target genes [102] . In vivo, the importance of MAML has been impressively demonstrated with dominant-negative MAML, which completely blocks all Notch-mediated transcriptional activation [106] . This tool has been exploited to study the physiological role of "canonical" (RBP-J dependent) Notch signaling in detail, reviewed in [107] . The ternary complex of RBP-J/NICD/MAML recruits histone acetyltransferase p300 to activate Notch target genes [45, 46, 108] . The Capobianco lab set out to purify the endogenous Notch-coactivator complex [109] . Using nuclear extracts from a T-cell leukemia line (SupT1), they could demonstrate in gel filtration experiments that this complex peaks at 1 -1.5MDa in size. The identity of further components still remains unresolved.
Structure of the RBP-J/NICD/MAML coactivator complex
The first detailed view of the transcription factor RBP-J (CSL) was provided by the determination of the structure of the C. elegans ortholog, Lag-1, bound to cognate DNA [110] . The structure revealed that RBP-J is composed of three domains: N-terminal (NTD), beta-trefoil (BTD) and C-terminal (CTD). The N-and C-terminal domains share structural similarities with the Rel-homology domain similar to those of NF-kB and NFAT proteins, reviewed in [104] . Previous biochemical and cellular studies demonstrated that both NICD and corepressors interact primarily with CSL through a central region corresponding to the beta-trefoil domain, reviewed in [104] . NICD primarily interacts strongly through its RAM-domain, but only weakly through its ankyrin repeats [94] . However, the ankyrin repeats are needed for the formation of the RBP-J/NICD/MAML ternary complex and transcriptional activation [10] . Several structures have been determined for the ankyrin repeats of NICD, including orthologs of mammals, D. melanogaster and C. elegans, reviewed in [104] . The ankyrin repeat fold is a common proteinprotein interaction motif and is composed of multiple repeats that form an elongated molecule; Each repeat contains two alpha helices connected by a turn and a beta-hairpin motif. Recently two ternary complex structures of RBP-J/NICD/MAML bound to DNA were determined for C. elegans [111] and human orthologous proteins [103] . The ternary complex reveals that Mastermind adopts a strikingly bent helical conformation, forming a tripartite structure with ankyrin repeats 3 -7 of NICD and the C-terminal domain of RBP-J (Fig. 2) . The crystal structures illuminate some of the molecular details fundamental to RBP-J and NICD. One should keep in mind that apart from RBP-J, only relatively small fragments of NICD and MAML were resolved. Understanding the complete coactivator complex, both functionally and structurally, remains a tremendous task for the future.
Negative regulators of activated Notch signaling NRARP and Deltex proteins are both important negative feedback regulators of Notch receptor mediated signaling. NRARP was first discovered in Xenopus and is a small 114 a.a. ankyrin-repeat containing protein [24] . NRARP is not only a direct Notch target gene [112] but interacts physically with NICD and blocks Notch-mediated transactivation and T lineage commitment [113, 114] . A similar observation was described for Deltex-1 [115] . Enforced expression of Deltex-1 in hematopoietic progenitor cells results in B-cell development at the expense of T-cell development [23] . However, in loss of function experiments, T-cells that lack Deltex-1 and Deltex-2 develop normally [116] . This means that endogenous levels of Deltex-1 and Deltex-2 are not important for regulating Notch signals.
CyclinC/Cdk8 and phosphorylation of Notch receptor
The Jones group has shown that Mastermind recruits CyclinC/Cdk8, which is part of the repressive Mediator complex [71] . This Cyclin/Cdk pair strongly enhances NICD phosphorylation and PEST-dependent degradation after ubiquitinylation by the Fbw7/ Sel10 ubiquitin ligase (Fig. 1) . The authors conclude that CyclinC/Cdk8 is important for Notch activation and turnover. The importance of Cdk8 as Notch kinase is challenged by the group of J. Aster; in this study a dominant-negative Cdk8 fails to affect the difference in NICD wild type and NICD mutated at all putative Cdk8 phosphorylation sites [117] . Thus, the role of CyclinC/Cdk8, and therefore of Mediator, remains controversial so far.
Notch signaling in development and differentiation
Notch signaling is activated upon cell-to-cell contact as a result of interactions between Notch receptors and their ligands Delta or Jagged. Signaling mediated by Notch receptors and ligands is involved in regulation of many biological functions, such as apoptosis, cell proliferation, differentiation and lineage decisions during embryonic development, and homeo- In Figure 3 , we summarize the different mechanisms of how Notch influences these key developmental decisions. Lateral inhibition (Fig. 3A) occurs during neurogenesis where a group of equipotent cells expressing equal amounts of Notch receptor and ligand begin to gradually express either Notch receptor or Notch ligand. In the case of lateral induction (Fig. 3B) , the Notch ligand is provided by a different cell in close proximity. A well-studied example for this is lymphopoiesis where a common lymphoid progenitor develops into a pre-T cell, in case a thymic stromal cell provides the inductive signal. In the absence of the inductive signal, i. e., in the bone-marrow environment, the common lymphoid progenitor differentiates into a B-cell with the help of bone marrow stromal cells. Notch can also maintain stem cell state and act as a gatekeeper (Fig. 3C ). An example for this is the intestine where Notch prevents the crypt progenitor cells (TA) from differentiating. On the other hand, Notch signaling can also drive a terminal differentiation program (Fig. 3D ) by inducing cell cycle arrest like it is observed in keratinocytes in the skin.
Notch regulates binary cell fate decisions and stem cell maintenance Notch signaling has been extensively studied first in Drosophila. The classical example is that Notch signaling restricts cell fates in the neural-epidermal choice. Special groups of cells known as proneural clusters have neuronal potential because of their expression of proneural helix-loop-helix transcriptional regulators. Notch signaling restricts neural differentiation by repressing the expression of proneural genes [118] . Failure to activate Notch signaling leads to formation of more neuronal clusters because of enhanced expression of proneural genes; constitutive activation of Notch signaling leads to the contrary and suppresses neural differentiation, reviewed in [2, 4] (Fig. 3A) . Many proteins that mediate neuronal repression in Drosophila are encoded by the Enhancer of Split complex, reviewed in [7, 119] . Therefore, Notch signaling seems to be an evolutionary conserved pathway for preventing equipotent cells from acquiring the same fate. In vertebrates, Notch signaling also represses neurogenesis (and myogenesis) via helix-loop-helix repressors called Hairy/Enhancer of split, or Hes, transcriptional repressors mentioned above. Taylor and colleagues could demonstrate that conditional ablation of Notch1 in mice leads to premature onset of neurogenesis [120] . Subsequently, they could show that Notch1 signaling is required for both neuron and glia formation. Using transgenic Hes5 promoter coupled to a GFP-reporter, two groups could show that the GFP expressing cells have self-renewal capability and multipotency in transplantation assays [121, 122] . An example of Notch signaling in vertebrates involved in stem cell maintenance is the intestinal crypt compartment in the gut, a highly proliferative tissue, reviewed in [123] . Post-natal gut specific inactivation of RBP-J results in the complete loss of proliferating transient amplifying (TA) cells [124] . In a reciprocal experiment, expression of activated Notch1 (NICD) in the gut inhibits differentiation of crypt progenitors [125] . These genetic experiments establish Notch signaling as a gatekeeper for intestinal crypt cells in mice. In pharmacological experiments using g-secre- 
Notch induces terminal differentiation
A second general role of Notch is to promote the development of a given cell type or body region, often by inducing the expression of positively acting regulatory molecules. For example, in Drosophila wing development, Notch signaling specifies the wing margin, a line of cells that organizes the outgrowth of the wing by activation of the gene vestigal, reviewed in [119] . In mammals, Notch signaling initiates a terminal differentiation program in human skin [127, 128] . In mouse keratinocytes, Notch signaling stimulates expression of early differentiation markers and enhances the expression of cell cycle regulator p21/ Waf1, causing cell-cycle arrest of basal cells and thus allowing onset of differentiation [28] (Fig. 3D ).
Notch in hematopoiesis
Fetal/adult stem cells In development, Notch is essential for the emergence of definitive hematopoietic stem cells during fetal life [129] . During the onset of definitive hematopoiesis in the embryo, Notch1/RBP-J dependent signaling leads to the activation of GATA-2 [130] , which has been shown to be an essential transcription factor for hematopoiesis [131] . Whether Notch signaling is similarly important for adult hematopoiesis remains controversial: Several studies using overexpression of activated form of Notch1 in primary cells as well as stimulation of hematopoietic stem cells with Notch ligand suggest that Notch inhibits differentiation leading to increased self-renewal, reviewed in [132] . In addition, Reya and colleagues used a transgenic Notch reporter mouse, with RBP-J responsive elements driving a GFP reporter, and could show that Notch signaling is active in GFP+ adult hematopoietic stem cells (HSCs) and is reduced in differentiated cells [133] . Inhibition of Notch leads to accelerated differentiation of HSCs in vitro and depletion of HSCs in vivo. On the other hand, none of the loss-of-function studies have demonstrated a role for the Notch/RBP-J signaling pathway in hematopoietic stem cell maintenance. Neither inducible knock-out of RBP-J [68] , Notch1 [134] or Jagged1 [135] have led to a reduction of hematopoietic stem cells. In addition, Pear and colleagues showed that HSCs that carry dominantnegative mastermind (dnMAML) can engraft normally in bone-marrow transplantation assays, and that normal frequencies in long-term reconstitution assays are achieved in both the presence or absence of dnMAML [136] .
T-cell development
The best-studied example in mammals is how Notch signaling determines a hematopoietic progenitor cell to differentiate into a T-lymphocyte (Fig. 3B) . The importance of Notch signaling for the induction of Tcell fate was first demonstrated in mice in which the Notch1 gene was conditionally deleted using Mx-Cre. These mice exhibited a complete block in T-cell development at an early stage of differentiation and an emergence of ectopic B-cell development in the thymus [134] . Conversely, overexpression of constitutive-active Notch (NICD) in the bone marrow instructed a T-cell fate in bone marrow progenitors and inhibited B-cell development [137] . The same effect was observed after overexpression of Delta4 in the thymus [138] . Ex vivo, this phenomenon has been exploited using bone marrow stromal cell lines expressing Notch ligand Delta-like1. T-cell precursors can be efficiently generated by co-culturing hemato- Cell. Mol. Life Sci. Vol. 66, 2009 Review Article 1639 poietic progenitors on these stromal Notch-ligand expressing cells [139] . Notch signaling also potentially plays a role in the development of gamma/delta T-cells and natural killer cell development, reviewed in [107, 140] . Recent data also indicate that Notch signaling can direct the differentiation and activity of peripheral T-cells, reviewed in [107, 141] . During helper T-cell differentiation, Notch is involved in generating optimal Th2 cell responses by upregulating GATA3 and thereby promoting IL-4 expression [21, 22] .
Notch and B-cell development
In addition to its well-established function in T-cell development, Notch signaling is important for later stages in B-cell development. Early stages of B-cell development do not depend on Notch signaling components and the B-cell master regulator Pax-5 even suppresses Notch1 expression, reviewed in [142] . Although Notch1 is the key Notch receptor during Tcell development, Notch-2 is the crucial receptor to fulfill functions in B-cells. Notch-2 is essential for the development of splenic marginal zone B-cell whereas it is dispensable for follicular B-cell [143] . This decision depends on Notch-2, its ligand Delta-1 as well as on RBP-J, reviewed in [140] . Recently, it was also shown that Notch signaling plays an important role in the terminal differentiation of mature B-cells into antibody-secreting cells [144] and that Notch activity can synergize with the B-cell receptor and CD40 signaling to enhance B-cell activation [145] .
Notch in myeloid/erythroid differentiation It has been shown that Notch1/RBP-J positively regulates apoptosis during erythroid development [146] . However, its role in myelopoiesis remains unclear and controversial. On the one hand, some in vitro studies show that activated Notch signaling inhibits differentiation of myeloid precursors [147 -149] . This is also supported by a recent work using a conditionally induced null mutation in the FX locus, that results in a myeloproliferative phenotype [150] . FX encodes an essential enzyme in the GDP-fucose synthesis pathway. In addition, FX is essential for the fucosylation of the EGF repeats of Notch, a crucial post-translational modification for proper Notch function [4] . On the other hand the group of Just has shown that a conditionally NICD, fused to the ligand binding domain of estrogen receptor promotes myeloid differentiation [151] . In loss-of-function studies, Radtke and colleagues could show that in conditional Notch1 deficient mice development of granulocytes, macrophages and dendritic cells is normal [152] . The same holds true for conditional RBP-J deficient mice [68] . In addition, in mice reconstituted with stem cells carrying a dominant negative form of Mastermind (dnMAML, see above), development of myeloid compartment is also not affected [136] . For further detailed information, readers are referred to several excellent in-depth reviews on the topic of Notch signaling in hematopoiesis, especially lymphopoiesis [107, 140, 153, 154] .
Notch signaling in cancer
There is increasing evidence that Notch signals are oncogenic in many cellular contexts, for example in Tcell leukemia (T-ALL), breast and colon cancer, reviewed in [123, 155] . Notch-4 was first identified as a proviral integration sites, named int-3, in retrovirus-induced murine mammary cancer [156] . Whether Notch4 plays a genuine role in normal mammary development remains unclear so far.
Notch and leukemia
The definite example of oncogenic Notch signaling is found in T-acute lymphoblastic leukemia (T-ALL), an aggressive neoplasm of immature T-cells. Human Notch was originally identified at a chromosomal breakpoint of a subset of T-ALLs containing a t(7;9) chromosomal translocation. These leukemic cells express a truncated Notch1 allele (TAN1), that encodes a constitutive-active Notch1 polypeptide [157] reviewed in [100] and [123] . In support of this, many studies in mice have subsequently revealed that expression of constitutive-active Notch proteins leads to potent and specific induction of T-ALL [158] . Aster and colleagues searched for specific Notch1 mutations in T-ALLs that do not harbor the t(7;9) translocation and identified two hotspot regions in the Notch1 gene: the heterodimerization and the PEST-domain [159] . Mutations in the heterodimerization domain enhance S3 cleavage of Notch and cause, via augmented NICD production, a significant increase in Notch signaling. Genetic and biochemical data suggest that loss of the PEST-domain enhance NICD protein stability, reviewed in [160] . Synergistic heterodimerization and PEST domain mutants are found together in cis in 10 -20 % of human T-ALLs [159] and low copy number amplification of Notch1 has also been reported [161] . Notch mutations appear to collaborate with a diverse collection of other proteins dysregulated in T-ALL. Retroviral oncogenesis in mice indicates a synergistic interaction between Notch1 and c-myc [162] , E2A/ pbx [163] and dominant negative forms of Ikaros [164] to enhance development of T-ALL. Apart from Notch1, Notch3 was consistently expressed in human T-ALL and dramatically reduced in clinical remission [165] . It was shown by the Screpanti group that Notch target genes Hes1 and preTa are associated with Notch3 expression. Expression of these genes is restricted to thymocytes and usually not seen in normal mature peripheral T-cells. Thus, the expression of Hes1, Notch3 and preTa characterizes the active and relapsing face of T-ALL, reviewed in [123] .
Notch target genes and herpes viruses (Epstein-Barr and Kaposis sarcoma-associated herpes viruses) The Epstein-Barr virus nuclear antigen 2 (EBNA2) and NICD have been shown to be partially interchangeable, reviewed in [166] . Therefore EBNA2 has been proposed to be the functional homolog of NICD. EBNA2 is a transcriptional transactivator that is one of the first viral genes expressed after EBV infection of B-cells and is essential for Epstein-Barr virus (EBV) immortalization of B-cells in vitro [167, 168] . EBNA2, like NICD, does not bind to DNA directly, but needs the transcription factor RBP-J [169, 170] . Recombinant viruses carrying an EBNA2 gene that lacks the RBP-J interaction domain are no longer able to immortalize B-cells [171] . EBNA2 and NICD are found to regulate the same cellular and viral promoters and both have been shown to be partially interchangeable in regard to activation of target genes in B-cell lines and modulation of differentiation processes, reviewed in [166] . In addition to EBV, the lytic switch protein RTA of Kaposis sarcoma-associated herpes virus (KSHV) has been found to bind to RBP-J [172] , reviewed in [173] . KSHV establishes latency in B-cells, like EBV, but can also infect endothelial cells. Other viruses that have interactions with the Notch pathway are adenovirus, HPV and simian virus 40 (SV40), reviewed [173] . The first association of adenovirus came from the recognition of a RBP-J binding site in the pIX promoter [5] . Subsequently, adenovirus 13SE1A was shown to bind to RBP-J and to be capable of activating promoters containing RBP-J binding sites [174] . Therefore, EBV, KSHV, HPV, SV40 and adenovirus encode proteins that bind to RBP-J and mimic certain aspects of Notch signaling. In this way the virus can manipulate the ability of the Notch signaling pathway to influence proliferation and differentiation processes.
Future perspectives
Understanding how different Notch target genes are activated or repressed in different cell types still remains enigmatic. In our view, the key for understanding this problem is the composition of the RBP-J associated corepressor and coactivator complexes and the epigenetic status of the relevant Notch target gene. Switch-on and switch-off systems for Notch signaling are now needed to analyze the dynamic molecular mechanism(s) of transcriptional regulation. Histone modifying enzymes, such as histone acetyltransferases and deacetylases (HDACs) as well as histone methylases and demethylases, have great potential in being drug targets; HDAC inhibitors are already used in clinical trials. Therefore, understanding the epigenetic regulatory mechanism controlling key Notch target genes could be translated into new therapeutic approaches, for example, in regard to leukemia.
